Virpax Engages Physicians Experienced In Childhood Epilepsy To Assist In Development Of CBD-Based Drug NobrXiol
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) has engaged two physicians experienced in childhood epilepsy, Dr. Kenneth W. Sommerville and Dr. Lawrence Fried, to support the overall development plan for NobrXiol.
